ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,728.80
      0.00%
      US Tech 100
      19,509.20
      0.06%
      Dow Jones
      42,052.19
      0.00%
      Brent Oil
      74.99
      1.24%
      Bitcoin
      68,589.99
      -0.22%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Biora Therapeutics Inc (BIOR) Quote

      Biora Therapeutics Inc

      Biora Therapeutics Inc (BIOR)

      NASDAQ
      3.3494
      -0.08
      (-2.35%)
      Closed November 01 4:00PM
      Delayed by 15 minutes
      3.3494
      0.00
      ( 0.00% )
      Pre Market: 8:43AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.3494
      Bid
      3.15
      Ask
      3.50
      Volume
      6
      0.00 Day's Range 0.00
      3.31 52 Week Range 19.90
      Market Cap
      12.318M
      Previous Close
      3.3494
      Open
      -
      Last Trade
      1
      @
      3.42
      Last Trade Time
      08:43:40
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      200,752
      Shares Outstanding
      3,677,747
      Dividend Yield
      -
      PE Ratio
      -0.10
      Earnings Per Share (EPS)
      -33.75
      Revenue
      4k
      Net Profit
      -124.12M

      About Biora Therapeutics Inc

      Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration de... Progenity Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Progenity Inc is primarely in the business of services-medical laboratories. For financial reporting their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents S-1 Prospectus Current Reports 8-K 10K Annual Reports filed by Progenity Inc.. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.bicara.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Biora Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BIOR. The last closing price for Biora Therapeutics was $3.35. Over the last year, Biora Therapeutics shares have traded in a share price range of $ 3.31 to $ 19.90.

      Biora Therapeutics currently has 3,677,747 shares outstanding. The market capitalization of Biora Therapeutics is $12.32 million. Biora Therapeutics has a price to earnings ratio (PE ratio) of -0.10.

      Ask ADVFN Intelligence (AI)

      BIOR Latest News

      More News

      FeaturedNorth Bay Resources Announces Assays up to 9.5% Copper at Murex Copper Project, British Columbia

      22 seconds ago

      Form 8-K - Current report

      October 29 2024
      Edgar (US Regulatory)

      Form 424B5 - Prospectus [Rule 424(b)(5)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Form 424B3 - Prospectus [Rule 424(b)(3)]

      October 29 2024
      Edgar (US Regulatory)

      Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

      SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive...

      October 29 2024
      GlobeNewswire Inc.

      Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting

      SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today is sharing progress on its development of the...

      October 28 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.9506-22.10697674424.34.423.31801163.6837022CS
      4-2.2906-40.61347517735.645.973.311849314.96569258CS
      12-3.0056-47.2950432736.3557.13.312007525.7776846CS
      26-4.1396-55.27573774877.4897.93.312212196.24938342CS
      52-15.7506-82.463874345519.119.93.313800199.99703895CS
      156-211.6506-98.4421395349215287.53.3187407097.99632089CS
      260-211.6506-98.4421395349215287.53.3187407097.99632089CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      STAFStaffing 360 Solutions Inc
      $ 3.50
      (105.88%)
      		11.84M
      NUWENewellis Inc
      $ 2.35
      (72.79%)
      		9.4M
      OMICSingular Genomics Systems Inc
      $ 21.70
      (61.22%)
      		93.97k
      VSTEVast Renewable Ltd
      $ 7.67
      (59.79%)
      		8.23M
      ADNAdvent Technologies Holdings Inc
      $ 2.65
      (39.47%)
      		5.38M
      ELABElevai Labs Inc
      $ 0.0236
      (-18.34%)
      		51.53M
      FGFFundamental Global Inc
      $ 18.50
      (-16.85%)
      		5.2k
      XTLBXTL Biopharmaceuticals Ltd
      $ 1.98
      (-15.74%)
      		18.67k
      EDSAEdesa Biotech Inc
      $ 2.70
      (-15.63%)
      		13.95k
      RILYTB Riley Financial Inc
      $ 9.70
      (-15.51%)
      		1.16k
      ELABElevai Labs Inc
      $ 0.0236
      (-18.34%)
      		51.53M
      STAFStaffing 360 Solutions Inc
      $ 3.50
      (105.88%)
      		11.84M
      NUWENewellis Inc
      $ 2.35
      (72.79%)
      		9.4M
      HRYUHanryu Holdings Inc
      $ 0.2421
      (13.18%)
      		9.09M
      VSTEVast Renewable Ltd
      $ 7.67
      (59.79%)
      		8.23M

      BIOR Discussion

      View Posts
      Monksdream Monksdream 2 days ago
      BIOR, new 52 week low
      👍️0
      The Night Stalker The Night Stalker 5 months ago
      nice
      👍️0
      Arnold25764 Arnold25764 6 months ago
      Any possible catalyst here?
      👍️0
      Monksdream Monksdream 7 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 7 months ago
      BIOR new 52 lo
      👍️0
      Monksdream Monksdream 7 months ago
      BIOR 10Q due 3/26
      👍️0
      Monksdream Monksdream 8 months ago
      BIOR under $2
      👍️0
      glenn1919 glenn1919 8 months ago
      BIOR.................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 8 months ago
      BIOR..................................https://stockcharts.com/h-sc/ui?s=BIOR&p=W&b=5&g=0&id=p86431144783
      👍️0
      Monksdream Monksdream 11 months ago
      BIOR new 52 week low
      👍️0
      Monksdream Monksdream 11 months ago
      BOIR new 52 week low
      👍️0
      Monksdream Monksdream 11 months ago
      BIOR new 52 week low
      👍️0
      TheFinalCD TheFinalCD 11 months ago
      https://finviz.com/quote.ashx?t=BIOR&p=d

      https://dilutiontracker.com/app/search/BIOR
      👍️0
      Awl416 Awl416 11 months ago
      Biora Therapeutics Announces FDA Clearance of IND Application for Drug/Device Combination BT-600 Targeting Treatment of Ulcerative Colitis
      👍️0
      retireat40 retireat40 1 year ago
      Looked good this morning at 2.66 but a crappy close.
      👍️0
      Monksdream Monksdream 1 year ago
      BIOR Barchart Bottom 100
      Biora Therapeutics Inc NASDAQ: BIOR



      GoSymbol lookup
      Health Care : Biotechnology | Small Cap ValueCompany profile
      Biora Therapeutics, Inc. is a biotechnology company, which is focused on creating smart pills designed for targeted drug delivery to the gastrointestinal (GI) tract, and needle-free delivery of biotherapeutics. The Company's therapeutics pipeline includes two therapeutic delivery platforms: NAVICAP and BIOJET. NAVICAP is a targeted oral delivery platform of therapeutics to the site of disease in the GI tract, designed to improve outcomes for patients with inflammatory bowel disease (IBD). The NAVICAP drug delivery device is an investigational, clinical-stage, single-use ingestible device approximately the size of a fish oil capsule. BIOJET is a systemic oral delivery platform of biotherapeutics designed to replace injection with needle-free, oral delivery of molecules for better management of chronic diseases. The Company's targeted therapeutics pipeline programs include NAVICAP, BT-600 and BT-001. Its systemic therapeutics pipeline programs include BIOJET, BT-200 and BT-002.
      👍️0

      Your Recent History

      NASDAQ
      BIOR
      Biora Therapeutics
      BIT
      P20Y69
      NLBNPIT20Y69 20250620 35...
      BIT
      I09773
      XS2733507052 20260209 0....
      BIT
      P1XD75
      NLBNPIT1XD75 20991231 10...
      Delayed Upgrade Clock